Evaluation of SCT800 in Prophylaxis Therapy on Previous Treated Patients With Severe Hemophilia A

NCT03815318 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

73

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilia A

Interventions

DRUG: Recombinant Human Coagulation FVIII

Sponsor

Sinocelltech Ltd.

Collaborators

[object Object]
[object Object]
[object Object]